Selected article for: "appropriate treatment and clinical disease"
Author: Kubina, Robert; Dziedzic, Arkadiusz
Title: Molecular and Serological Tests for COVID-19. A Comparative Review of SARS-CoV-2 Coronavirus Laboratory and Point-of-Care Diagnostics
  • Cord-id: tb1zsuw4
  • Document date: 2020_6_26
    • ID: tb1zsuw4
    Snippet: Validated and accurate laboratory testing for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a crucial part of the timely management of Coronavirus Disease 2019 (COVID-19) disease, supporting the clinical decision-making process for infection control at the healthcare level and detecting asymptomatic cases. This would facilitate an appropriate treatment, a prompt isolation and consequently deceleration of the pandemic. Various laboratory tests can identify the genetic material o
    Document: Validated and accurate laboratory testing for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a crucial part of the timely management of Coronavirus Disease 2019 (COVID-19) disease, supporting the clinical decision-making process for infection control at the healthcare level and detecting asymptomatic cases. This would facilitate an appropriate treatment, a prompt isolation and consequently deceleration of the pandemic. Various laboratory tests can identify the genetic material of SARS-CoV-2 that causes COVID-19 in specimens, or specific anti-viral antibodies in blood/serum. Due to the current pandemic situation, a development of point-of-care diagnostics (POCD) allows us to substantially accelerate taking clinical decisions and implement strategic planning at the national level of preventative measures. This review summarizes and compares the available POCD and those currently under development, including quantitative reverse transcription PCR (RT-qPCR), serology immunoassays (SIAs) and protein microarray method (PMM) designed for standard and rapid COVID-19 diagnosis.

    Search related documents:
    Co phrase search for related documents
    • absence presence and active infection: 1, 2, 3
    • absence presence and active virus: 1, 2, 3
    • absence presence and acute respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • absence presence and additional equipment: 1
    • absence presence and admission hospital: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • accuracy specificity and active infection: 1, 2
    • accuracy specificity and acute respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • accuracy specificity and additional advantage: 1
    • accuracy specificity and additional equipment: 1
    • accuracy specificity and adequate accuracy: 1
    • accuracy specificity and admission hospital: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • accuracy specificity diagnostic sensitivity and acute respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • accuracy specificity diagnostic sensitivity and admission hospital: 1
    • active infection and acute respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • active infection and additional advantage: 1
    • active infection and admission hospital: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • active infection patient and acute respiratory: 1, 2, 3, 4, 5
    • active infection patient and admission hospital: 1
    • active virus and acute respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25